Richard Travers is an Oncology physician affiliated with Tufts Medical Center. OpenAlex indexes 33 publications with 1,693 citations (h-index 14).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
800 Washington St
Boston, MA 021111552
Telephone
617-636-7227Provider last certified this registry record 3 Jul 2023.
Medicare prescribing footprint (2021)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
66.7%Corticosteroid66.7%Prednisone100%Part D<11 patientsBlood & clotting
33.3%Factor Xa inhibitor33.3%Eliquis100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2022–2023 per NIH RePORTER. The latest:
- Endothelium as a mediator of BCR-ABL tyrosine kinase inhibitor vascular toxicity
Tufts Medical Center
FY2023$65,897F32HL165838 - Endothelium as a mediator of BCR-ABL tyrosine kinase inhibitor vascular toxicity
Tufts Medical Center
FY2022$71,734F32HL165838
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Endothelium as a Source of Cardiovascular Toxicity From Antitumor Kinase Inhibitors
Arteriosclerosis Thrombosis and Vascular Biology
2024 - Antipolyphosphate monoclonal antibodies derived from autoimmune mice
Research and Practice in Thrombosis and Haemostasis
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Andrew Levey, MD
Tufts Medical Center
Mark Sarnak, MD
Tufts Medical Center
James Udelson, MD
Tufts Medical Center
Nicholas Hill, MD
Tufts Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”